The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Purpose
As a result of the COVID-19 pandemic, the Therapeutic Goods Administration (TGA) is receiving an increased number of enquiries from people seeking to develop medical devices or component parts of medical devices including using 3D printing or other advanced manufacturing technology.
The following guidance aims to assist manufacturers of medical devices and their component parts with meeting their regulatory obligations.